<?xml version="1.0" encoding="utf-8"?>
<law>
    <structure>
        <unit label="part" identifier="1" order_by="1" level="1">Administration Of The Government</unit>
        <unit label="title" identifier="22" order_by="22" level="2">Corporations</unit>
        <unit label="chapter" identifier="176G" order_by="176G" level="3">Health Maintenance Organizations</unit>
    </structure>
    <section_number>4Q</section_number>
    <catch_line>Coverage For Human Leukocyte Or Histocompatibility Locus Antigen Testing</catch_line>
    <order_by>4Q</order_by>
    <text>
        Any group health maintenance contract, except contracts providing supplemental coverage to Medicare or to other government programs, delivered, issued or renewed by agreement within or without the commonwealth shall provide to a member or enrollee coverage for the cost of human leukocyte antigen testing or histocompatibility locus antigen testing that is necessary to establish the member’s or enrollee’s bone marrow transplant donor suitability. The coverage shall cover the costs of testing for A, B or DR antigens, or any combination thereof, consistent with rules, regulations and criteria established by the department of public health pursuant to section 218 of chapter 111.
    </text>
</law>